2026 WINTER PRODUCT RELEASE
Advancing clinical excellence and expanding access to care
Introducing contingency management, now integrated into our clinical model, and a new stimulants program — deepening clinical excellence while expanding access to a population with historically limited treatment options.
Contingency management for substance use care
Contingency management is one of the most evidence-backed interventions in addiction medicine. It’s now built directly into a member’s care plan — working alongside cognitive behavioral therapy and motivational enhancement therapy as part of how Pelago treats.
2x
Appointment attendance vs. non-CM members
4x
Daily check-in rate vs. non-CM members
82%
Of eligible members enrolled and participating
1.5x
More likely to stay engaged at 30 days
Inside the member experience
See how contingency management works for members, from first appointment to redemption
Stimulant use disorder program
9 million Americans misused stimulants in the past year, and 4.3 million had a stimulant use disorder. For most of them, the right treatment hasn’t been available. Pelago is changing that.
The gold standard, built in
The same care model that drives outcomes across Pelago's programs, including CBT, contingency management, and coaching is the foundation of our approach to stimulant use disorder treatment.
Specialty care for stimulants
Most platforms list stimulants as covered. Pelago is building a program specifically designed for how stimulant use disorder presents, progresses, and responds to treatment.
Care built for real-life
Members get the same stigma-free, virtual-first experience as any Pelago program with same-day access, a dedicated care team, and support that fits around their life. Available to members 15 and older.
A program backed by results
Pelago's care model has demonstrated measurable clinical impact and medical cost savings across our member population, independently validated by Aon.
Say hello to brighter days together
Get started quickly. Reduce healthcare spend. Change lives forever.
